Metacen Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Metacen Therapeutics General Information

Description

Developer of metabolic health therapies designed for the management of metabolic disease pathways. The company's platform utilizes AGE-reduction technologies, probiotic-based research, metabolic disease studies, and therapeutic development activities, enabling healthcare and life sciences organizations to support disease prevention, metabolic health management, and treatment research.

Contact Information

Website
www.metacen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 91, Changryong-daero 256beon-gil, Yeongtong-gu
  • 1007, 10th Floor, 16229
  • Suwon, Gyeonggi 443-270
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 91, Changryong-daero 256beon-gil, Yeongtong-gu
  • 1007, 10th Floor, 16229
  • Suwon, Gyeonggi 443-270
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Metacen Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Pre-Clinical Trials
3. Later Stage VC (Series B) 16-Apr-2021 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 01-Jan-2017 $2.69M $3.54M Completed Startup
1. Seed Round 01-Jan-2016 $847K $847K Completed Startup
To view Metacen Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Metacen Therapeutics Patents

Metacen Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026054258-A1 Composition for treating fatty liver comprising lactococcus lactis strain, amino acids, and vitamin Pending 03-Sep-2024
WO-2025170200-A1 Novel composition comprising wheat germ extract Pending 06-Feb-2024
WO-2025170198-A1 Zinc transporter activator composition Pending 06-Feb-2024
WO-2023234620-A1 Novel strain having resistance to methylglyoxal and use thereof Inactive 03-Jun-2022
JP-2024536636-A A novel strain having antagonistic activity against proteus mirabilis and having excellent effects on neurodegenerative diseases, and its use Active 19-Oct-2021 A61K35/744
To view Metacen Therapeutics’s complete patent history, request access »

Metacen Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Metacen Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
DA Value Investment Growth/Expansion Minority
Gravity Ventures (Korea) Corporate Venture Capital Minority
Vision Creator Venture Capital Minority
To view Metacen Therapeutics’s complete investors history, request access »

Metacen Therapeutics FAQs

  • When was Metacen Therapeutics founded?

    Metacen Therapeutics was founded in 2015.

  • Where is Metacen Therapeutics headquartered?

    Metacen Therapeutics is headquartered in Suwon, South Korea.

  • What is the size of Metacen Therapeutics?

    Metacen Therapeutics has 24 total employees.

  • What industry is Metacen Therapeutics in?

    Metacen Therapeutics’s primary industry is Drug Discovery.

  • Is Metacen Therapeutics a private or public company?

    Metacen Therapeutics is a Private company.

  • What is Metacen Therapeutics’s current revenue?

    The current revenue for Metacen Therapeutics is .

  • How much funding has Metacen Therapeutics raised over time?

    Metacen Therapeutics has raised $9M.

  • Who are Metacen Therapeutics’s investors?

    DA Value Investment, Gravity Ventures (Korea), and Vision Creator have invested in Metacen Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process